Prevention of lymphocyte apoptosis in septic mice with cancer increases mortality.
Prevention of lymphocyte apoptosis in septic mice with cancer increases mortality.
复制标题
DOI:
10.4049/jimmunol.1003391
复制
发表时间:
2011-08-15
期刊:
影响因子:
--
通讯作者:
Coopersmith CM
中科院分区:
文献类型:
--
作者:
Fox AC;Breed ER;Liang Z;Clark AT;Zee-Cheng BR;Chang KC;Dominguez JA;Jung E;Dunne WM;Burd EM;Farris AB;Linehan DC;Coopersmith CM
Lymphocyte apoptosis is thought to play a major role in the pathophysiology of sepsis. However, there is a disconnect between animal models of sepsis and patients with the disease, since the former use subjects that were healthy prior to the onset of infection while most patients have underlying comorbidities. The purpose of this study was to determine whether lymphocyte apoptosis prevention is effective in preventing mortality in septic mice with pre-existing cancer. Mice with lymphocyte Bcl-2 overexpression (Bcl-2-Ig) and wild type (WT) mice were injected with a transplantable pancreatic adenocarcinoma cell line. Three weeks later after development of palpable tumors, all animals received an intratracheal injection of Pseudomonas aeruginosa. Despite having decreased sepsis-induced T and B lymphocyte apoptosis, Bcl-2-Ig mice had markedly increased mortality compared to WT mice following Pseudomonas aeruginosa pneumonia (85% vs. 44% seven-day mortality, p=0.004). The worsened survival in Bcl-2-Ig mice was associated with increases in Th1 cytokines TNF-α and IFN-γ in bronchoalveolar lavage fluid and decreased production of the Th2 cytokine IL-10 in stimulated splenocytes. There were no differences in tumor size or pulmonary pathology between Bcl-2-Ig and WT mice. To verify the mortality difference was not specific to Bcl-2 overexpression, similar experiments were performed in Bim-/- mice. Septic Bim-/- mice with cancer also had increased mortality compared to septic WT mice with cancer. These data demonstrate that despite overwhelming evidence that prevention of lymphocyte apoptosis is beneficial in septic hosts without comorbidities, the same strategy worsens survival in mice with cancer that are given pneumonia.
登录
查看更多内容
DOI:
10.1073/pnas.96.25.14541
发表时间:
1999-12-07
影响因子:
11.1
作者:
Hotchkiss, RS;Tinsley, KW;Karl, IE
通讯作者:
Karl, IE
影响因子:
20.3
作者:
Lamkanfi, Mohamed;Moreira, Lilian O.;Kanneganti, Thirumala-Devi
通讯作者:
Kanneganti, Thirumala-Devi
DOI:
10.1073/pnas.1031788100
发表时间:
2003-05-27
影响因子:
11.1
作者:
Hotchkiss, RS;Chang, KC;Karl, IE
通讯作者:
Karl, IE
影响因子:
3.1
作者:
Husain, KD;Stromberg, PE;Coopersmith, CM
通讯作者:
Coopersmith, CM
影响因子:
7.5
作者:
Delogu, G.;Famularo, G.;Moretti, S.
通讯作者:
Moretti, S.